CARDIOGENIC SHOCK POST MYOCARDIAL INFARCTION
Clinical trials for CARDIOGENIC SHOCK POST MYOCARDIAL INFARCTION explained in plain language.
Never miss a new study
Get alerted when new CARDIOGENIC SHOCK POST MYOCARDIAL INFARCTION trials appear
Sign up with your email to follow new studies for CARDIOGENIC SHOCK POST MYOCARDIAL INFARCTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Designer cells aim to calm immune system after massive heart attack
Disease control Not yet recruitingThis early-phase trial tests a new treatment for people in shock after a severe heart attack. The therapy uses specially engineered immune cells (CAR-DC) to target a protein found in heart scar tissue, aiming to calm the immune response. The study will enroll 18 patients and prim…
Matched conditions: CARDIOGENIC SHOCK POST MYOCARDIAL INFARCTION
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Hong kong launches study to track heart shock survival
Knowledge-focused Not yet recruitingThis study will track 320 people in Hong Kong who have a heart attack complicated by cardiogenic shock, a life-threatening condition where the heart can't pump enough blood. Researchers will collect data on standard treatments, including the use of a heart pump called Impella, to…
Matched conditions: CARDIOGENIC SHOCK POST MYOCARDIAL INFARCTION
Sponsor: Prince of Wales Hospital, Shatin, Hong Kong • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC